MENUNews Archive
Date: 10/24/2013
Eric Fearon among 3 U-M faculty members in this year's class.
Date: 10/16/2013
Adrenal cancer researchers at the University of Michigan Rogel Cancer Center are seeing the results of their laboratory studies translate to a clinical trial to test a potential new therapy in patients.
Date: 10/08/2013
Ann Arbor-area residents have one last opportunity to join the movement to create a world with less cancer and more birthdays by participating in Cancer Prevention Study-3 (CPS-3), a historic study that has the potential to change the face of cancer for future generations.
Date: 10/07/2013
About a quarter of women experience moderate to severe pain for many years after their treatment ends. In many cases, it's a type of pain that is challenging to treat, with few or no effective options.
Date: 10/03/2013
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood -- and it can support the cells' growth for further analysis.
Date: 09/26/2013
Michigan Medicine has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorporates three specific markers that could indicate cancer and studies have shown that the combination is far more accurate than PSA alone.
Date: 09/23/2013
Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends but a recent study by University of Michigan Rogel Cancer Cetner researchers have found that's not necessarily the case.
Date: 09/06/2013
Written by Kara Gavin; contact via email or at 734-764-2220.
Date: 09/06/2013
A new study from researchers at the University of Michigan Rogel Cancer Center found that these cells, called myeloid derived suppressor cells, provide a niche where the cancer stem cells survive.